Stockreport

Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights

Tectonic Therapeutic, Inc.  (TECX) 
PDF Patient enrollment in the Phase 1b hemodynamic trial remains ahead of expectation, with topline results now expected in late Q1’2025 or early Q2’2025First subject dosed [Read more]